The recently approved medication, Mounjaro, is creating considerable buzz within the healthcare community as a significant option for treating Non-Insulin-Dependent Metabolic Disorder. Unlike some traditional approaches, Mounjaro utilizes a dual action , targeting both gut hormone receptors and the second receptor, leading to enhanced blood sugar m